The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO‐3 trial
Anton Camaj(Columbia University Irving Medical Center), George Dangas(Mount Sinai Hospital), Bimmer E. Claessen(Columbia University Irving Medical Center), Hans Ulrich Hink(Johannes Gutenberg University Mainz), M. Yudi(Austin Health), Samantha Sartori(Icahn School of Medicine at Mount Sinai), Annapoorna Kini(Mount Sinai Medical Center), Sabato Sorrentino(Magna Graecia University), Samin K. Sharma(Mount Sinai Health System), Thierry Lefèvre(Hôpital Privé Jacques Cartier), Éric Van Belle, David Power(Cardiovascular Institute of the South), Prodromos Anthopoulos(Arena Pharmaceuticals (United States)), Gennaro Giustino(Cardiovascular Institute of the South), Christian Kupatt(München Klinik), Efthymios Deliargyris(CytoSorbents (United States)), Jaya Chandrasekhar(Icahn School of Medicine at Mount Sinai), David Hildick‐Smith(Sussex County Community College), Usman Baber(Icahn School of Medicine at Mount Sinai), John Webb(St. Paul's Hospital), Christian Hengstenberg(Medical University of Vienna), Roxana Mehran(Mount Sinai Hospital), Paul Guedeney(Université Paris Cité)
Cited by 1
Related Papers
2024 ESC Guidelines for the management of chronic coronary syndromes
|European Heart Journal|2024|2.3k
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
|New England Journal of Medicine|2016|1.5k
Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
|New England Journal of Medicine|2013|918
Frailty in Older Adults Undergoing Aortic Valve Replacement
|Journal of the American College of Cardiology|2017|785